The mortality rate for bladder malignant neoplasms in the United States, expressed in thousands of deaths, shows a slow but steady decline from 2024 to 2028. The forecasted data shows a minor year-on-year decrease of about 0.06% annually. In comparison to 2023, the prior year, where the value stood at approximately 16.74 thousand deaths, this gradual reduction indicates a trend towards improved outcomes and possibly better management or early detection of bladder cancer.

Future trends to watch for include:

Advancements in early detection technologies and their impact on mortality rates.
Improvement in treatment methods and accessibility affecting future forecasts.
Overall changes in healthcare policy impacting cancer care and prevention efforts.